In smokers with NSCLC, patients who obtained CR/PR/SD had a significantly lower IDO1 IRS (median: 4, range: 1–9) than those who developed PD (median: 8, range: 2–12; Fig. 3h). This evidence concerns the gene IDO1 and non-small cell lung carcinoma.